千红制药 (002550.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(千红制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 461,101,487.651,814,268,908.891,465,941,311.211,056,756,137.67608,218,905.422,303,547,790.851,648,829,042.011,136,885,809.73552,220,533.56
 营业利润(元) 117,007,469.48204,356,523.60194,339,441.17134,683,297.94102,232,381.64360,006,472.64243,460,032.56175,828,559.7993,816,402.19
 利润总额(元) 116,834,898.90203,523,478.93218,776,319.04134,760,019.43102,356,233.78360,330,425.31301,961,473.23234,109,504.90151,803,912.40
 净利润(元) 101,346,703.53178,672,039.16187,652,324.30113,669,982.9883,549,827.62319,910,826.87257,198,189.23195,746,011.55125,796,128.32
 归属于母公司股东的净利润(元) 104,108,160.35181,860,747.32197,855,106.96119,025,836.9485,946,847.70323,414,382.52268,398,353.54201,856,775.83128,247,521.34
盈利能力:
 销售毛利率(%) 53.1443.2642.9341.8139.2538.5939.4138.1740.48
 销售净利率(%) 21.989.8512.8010.7613.7413.8915.6017.2222.78
 净资产收益率(%) 4.207.418.155.213.59----
 总资产报酬率ROA(%) 4.037.087.704.563.80----
 投入资本回报率ROIC(%) 4.187.197.854.553.1913.5711.298.825.50
营运能力:
 存货周转率(次) 0.361.811.431.100.72----
 应收账款周转率(次) 1.204.593.952.261.34----
 总资产周转率(次) 0.160.650.530.380.21----
偿债能力:
 资产负债率(%) 10.8310.569.4619.1617.9213.2814.5817.3716.82
 股东权益比率(%) 88.5788.7590.1181.6082.7187.3386.1583.2183.61
 已获利息倍数(倍) -889.13-30.84-31.44-15.1815.32-3.86-2.43-3.3943.77
 流动比率 7.587.908.933.644.186.065.454.564.74
 速动比率 5.044.844.691.932.493.963.613.403.66
发展能力:
 营业收入增长率(%) -24.19-21.24-11.09-7.0510.1422.8620.5030.2341.16
 营业利润增长率(%) 14.45-43.24-20.18-23.408.9771.9712.3562.4536.94
 税后利润增长率(%) 21.13-43.77-26.28-41.03-32.9878.6041.32126.42135.93
 净资产增长率(%) -4.700.193.379.4512.4215.1912.127.475.70
 总资产增长率(%) -11.01-1.42-1.1711.6113.6311.8616.9016.4214.06

前瞻产业研究院